首页 > 市场调查报告书 > 医疗设备

体外诊断

到 2030 年北美传染病诊断市场预测 - 区域分析 - 按产品、技术、应用类型、测试类型和最终用户

市场调查报告书

商品编码

1494303

到 2030 年北美传染病诊断市场预测 - 区域分析 - 按产品、技术、应用类型、测试类型和最终用户

North America Infectious Disease Diagnostics Market Forecast to 2030 - Regional Analysis - By Product, Technology, Application Type, Testing Type, and End User

出版日期: 2024年03月14日 | 出版商:

The Insight Partners | 英文 115 Pages | 订单完成后即时交付

价格

简介目录图表

2022年北美传染病诊断市值为186.8443亿美元，预计到2030年将达到287.1807亿美元；预计2022年至2030年复合年增长率为5.5%。

对传染病诊断研发和资金的日益关注推动北美传染病诊断市场

研究与开发（R&D）是製药和生物製药公司业务的重要组成部分。研发使市场参与者能够为各种治疗应用开发出具有巨大医疗和商业潜力的新产品。此外，领先的市场参与者投资研发以开发先进技术并产生更多收入。为了应对不断增加的传染病病例以及实验室能力和分子检测试剂的短缺，一些诊断检测製造商提供快速且易于使用的设备来促进实验室外检测。简单的检测试剂盒可以检测样本中的病原体蛋白质或血液或血清中感染而产生的人类抗体。

以下是製造商采取的一些关键融资倡议的清单：

2022 年 3 月，全球抗爱滋病、疟疾和结核病基金对加拿大向全球基金的 COVID-19 应对机制 (C19RM) 捐款 6,000 万加元（4,399 万美元）的决定表示讚赏。这笔资金将有助于向低收入和中等收入国家提供挽救生命的诊断测试、治疗和个人防护装备（PPE）。
2021年9月，拜登-哈里斯政府投资21亿美元，加强美国公共卫生和医疗保健部门的感染控制和预防活动。拜登-哈里斯政府透过疾病预防控制中心运作，为美国救援计画投入资金，以解决美国各州、地方和地区卫生部门以及其他合作组织有关传染病的问题。

因此，对传染病诊断研发和资金的日益关注预计将为北美传染病诊断市场的成长创造有利可图的机会。

北美传染病诊断市场概况

美国传染病诊断市场的成长主要是由传染病患者病率的增加、老年人口的增加以及主要参与者推出的产品数量的增加所推动的。老化是传染病的重要危险因素，因为 60 岁以上的人免疫力普遍下降。根据人口资料局2020年发布的研究报告，2020年美国65岁及以上人口为5500万，预计到2060年将达到9500万。即时护理(POC) 产品的政策。例如，2021 年 3 月，美国食品药物管理局 (FDA) 授权 Binx Health IO CT/NG Assay 用于社区诊所、紧急护理机构和门诊医疗机构；它是第一个用于诊断衣原体和淋病感染的 POC 检测产品。 2022 年 5 月，全球领先的医疗科技公司之一 Becton Dickinson and Company (BD) 宣布在美国市场推出其新型全自动、高通量传染病分子诊断平台。新型 BD COR MX 仪器是作为 BD COR 平台的分析仪器选项推出，并获得 FDA 510(k) 许可。 BD CTGCTV2 分子测定是新系统上可用的第一个测试，是一种单一测试，可检测三种最受欢迎的非病毒性传播感染(STI)——淋病奈瑟菌(GC)、沙眼衣原体(CT ) 和阴道滴虫（电视）。

北美传染病诊断市场收入及 2030 年预测（百万美元）

北美传染病诊断市场细分

北美传染病诊断市场根据产品、技术、应用类型、测试类型、最终用户和国家进行细分。

根据产品，北美传染病诊断市场分为试剂盒和试剂、仪器以及软体和服务。 2022 年，试剂盒和试剂细分市场占最大份额。

依技术划分，北美传染病诊断市场分为基于生物感测器、免疫诊断、基于分子的诊断技术、临床生物学等。到 2022 年，免疫诊断领域占据最大份额。以分子为基础的诊断技术细分为聚合酶连锁反应（PCR）、原位杂交、等温核酸扩增技术（INAAT）、次世代定序（NGS）、DNA微阵列等。

按应用类型划分，北美传染病诊断市场分为实验室检测和即时检测。 2022 年，实验室测试领域占据了更大的份额。

按测试类型划分，北美传染病诊断市场分为人体测试和兽医测试。到2022年，人体检测部分将占据更大的份额。

依最终用户划分，北美传染病诊断市场分为诊断实验室、医院和诊所、研究机构、家庭护理机构等。 2022 年，诊断实验室领域占最大份额。

按国家/地区划分，北美传染病诊断市场分为美国、加拿大和墨西哥。 2022年，美国将主导北美传染病诊断市场。

Abbott Laboratories、Bruker Corp、Cardinal Health Inc、F. Hoffmann-La Roche Ltd、Trinity Biotech Plc、Danaher Corp、Bio-Rad Laboratories Inc、ACON Laboratories Inc 和 DiaSorin SpA 是北美传染病领域的一些领先公司诊断市场。

Research and development (R&D) is an essential component of the business of pharmaceutical and biopharmaceutical companies. R&D enables market players to come up with new products for various therapeutic applications with significant medical and commercial potential. Moreover, leading market players invest in R&D to develop advanced technologies and generate more revenue. In response to the growing cases of infectious diseases and the shortage of laboratory capabilities and molecular testing reagents, some diagnostic testing manufacturers offer fast and easy-to-use devices to facilitate out-of-laboratory testing. The simple test kits detect proteins of pathogens from samples or human antibodies that are produced in response to infection in blood or serum.

Following is a list of a few key funding initiatives undertaken by the manufacturers:

In March 2022, the Global Fund to Fight AIDS, Malaria, and Tuberculosis acclaimed the decision by Canada to contribute CAD 60 million (US$ 43.99 million) to the Global Fund's COVID-19 Response Mechanism (C19RM). The funding will help provide life-saving diagnostic tests, treatments, and personal protective equipment (PPE) to low- and middle-income countries.
In September 2021, the Biden-Harris Administration invested US$ 2.1 billion to enhance infection control and prevention activities across the US public health and healthcare sectors. The Biden-Harris administration, operating through the CDC, invested funds in the US rescue programs to address state, local, and territorial health departments and other partner organizations about infectious diseases in the US.

Thus, rising focus on R&D and funding in infectious disease diagnostics is expected to create lucrative opportunities for the growth of the North America infectious disease diagnostics market.

North America Infectious Disease Diagnostics Market Overview

The infectious diseases diagnostics market growth in the US is primarily driven by the increasing prevalence of infectious diseases, rising geriatric population, and growing number of product launches by key players. Aging is a prominent risk factor for infectious diseases as people above 60 generally have compromised immunity. According to a study published by the Population Reference Bureau in 2020, the population of individuals aged 65 and above was 55 million in the US in 2020, and the number is expected to reach 95 million by 2060. Regulatory agencies in the US are imposing favorable policies for the development of point-of-care (POC) products for the diagnosis and treatment of various indications. For instance, in March 2021, the US Food Drug Administration (FDA) authorized Binx Health IO CT/NG Assay for community-based clinics, urgent care settings, and outpatient healthcare facilities; it is the first POC testing product for diagnosing chlamydial and gonorrheal infections. In May 2022, Becton Dickinson and Company (BD), one of the leading global medical technology companies, announced the launch of its new, fully automated, high-throughput molecular diagnostics platform for infectious diseases for the market in the US. The new BD COR MX instrument was launched as an analytical instrument option for the BD COR platform, with 510(k) clearance from the FDA. The BD CTGCTV2 molecular assay, the first test available on the new system, is a single test that detects the three most prevalent non-viral sexually transmitted infections (STIs)-Neisseria gonorrhoeae (GC), Chlamydia trachomatis (CT), and Trichomonas vaginalis (TV).

North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Million)

North America Infectious Disease Diagnostics Market Segmentation

The North America infectious disease diagnostics market is segmented based on product, technology, application type, testing type, end user, and country.

Based on product, the North America infectious disease diagnostics market is segmented into kits & reagents, instruments, and software & services. The kits & reagents segment held the largest share in 2022.

By technology, the North America infectious disease diagnostics market is segmented into biosensor-based, immunodiagnostics, molecular-based diagnostic techniques, clinical biology, and others. The immunodiagnostics segment held the largest share in 2022. The immunodiagnostics segment is further subsegmented into enzyme-linked immunosorbent assay (ELISA), western blotting analysis, and immunofluorescence assay. The molecular-based diagnostic techniques segment is further subsegmented into polymerase chain reaction (PCR), in situ hybridization, isothermal nucleic acid amplification technology (INAAT), next-generation sequencing (NGS), DNA microarrays, and others.

By application type, the North America infectious disease diagnostics market is bifurcated into laboratory testing and point-of-care testing. The laboratory testing segment held a larger share in 2022.

By testing type, the North America infectious disease diagnostics market is bifurcated into human testing and veterinary testing. The human testing segment held a larger share in 2022. The human testing segment is further subsegmented into HIV, hepatitis, HAIs, HPV, tuberculosis, influenza, and others.

By end user, the North America infectious disease diagnostics market is segmented into diagnostic laboratories, hospitals & clinics, research institutes, homecare settings, and others. The diagnostic laboratories segment held the largest share in 2022.

Based on country, the North America infectious disease diagnostics market is segmented into the US, Canada, and Mexico. The US dominated the North America infectious disease diagnostics market in 2022.

Abbott Laboratories, Bruker Corp, Cardinal Health Inc, F. Hoffmann-La Roche Ltd, Trinity Biotech Plc, Danaher Corp, Bio-Rad Laboratories Inc, ACON Laboratories Inc, and DiaSorin SpA are some of the leading companies operating in the North America infectious disease diagnostics market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 North America Infectious Disease Diagnostics Market, by Country (US$ Million)

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Infectious Disease Diagnostics Market - Key Industry Dynamics

4.1 Market Drivers:
- 4.1.1 Rising Incidence of Infectious Diseases
- 4.1.2 Rising Application of Diagnostics in Veterinary Infectious Disease
4.2 Market Restraints
- 4.2.1 Inadequate Reimbursement Scenario
4.3 Market Opportunities
- 4.3.1 Increasing Focus on R&D and Funding in Infectious Disease Diagnostics
4.4 Future Trends
- 4.4.1 Rising Number of Product Approvals and Launches
4.5 Impact Analysis:

5. Infectious Disease Diagnostics Market - North America Market Analysis

5.1 North America Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030

6. North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Product

6.1 Overview
6.2 North America Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)
6.3 Kits & Reagents
- 6.3.1 Overview
- 6.3.2 Kits & Reagents: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Instruments
- 6.4.1 Overview
- 6.4.2 Instruments: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Software & Services
- 6.5.1 Overview
- 6.5.2 Software & Services: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

7. North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Technology

7.1 Overview
7.2 North America Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)
7.3 Biosensor-based
- 7.3.1 Overview
- 7.3.2 Biosensor-based: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Immunodiagnostics
- 7.4.1 Overview
- 7.4.2 Immunodiagnostics: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.4.2.1 North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
7.5 Molecular-Based Diagnostic Techniques
- 7.5.1 Overview
- 7.5.2 Molecular-Based Diagnostic Techniques: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 7.5.2.1 North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
7.6 Clinical Biology
- 7.6.1 Overview
- 7.6.2 Clinical Biology: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Application Type

8.1 Overview
8.2 North America Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)
8.3 Point-of-Care Testing
- 8.3.1 Overview
- 8.3.2 Point-of-Care Testing: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Laboratory Testing
- 8.4.1 Overview
- 8.4.2 Laboratory Testing: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by Testing Type

9.1 Overview
9.2 North America Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)
9.3 Human Testing
- 9.3.1 Overview
- 9.3.2 Human Testing: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  - 9.3.2.1 North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
9.4 Veterinary Testing
- 9.4.1 Overview
- 9.4.2 Veterinary Testing: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 - by End User

10.1 Overview
10.2 North America Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)
10.3 Diagnostic Laboratories
- 10.3.1 Overview
- 10.3.2 Diagnostic Laboratories: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.4 Hospitals and Clinics
- 10.4.1 Overview
- 10.4.2 Hospitals and Clinics: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.5 Research Institutes
- 10.5.1 Overview
- 10.5.2 Research Institutes: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.6 Homecare Settings
- 10.6.1 Overview
- 10.6.2 Homecare Settings: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
10.7 Others
- 10.7.1 Overview
- 10.7.2 Others: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Infectious Disease Diagnostics Market - Country Analysis

11.1 North America Infectious Disease Diagnostics Market - Country Analysis
- 11.1.1 North America Infectious Disease Diagnostics Market, by Country
  - 11.1.1.1 US
    - 11.1.1.1.1 Overview
    - 11.1.1.1.2 US: North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.1.3 US: North America Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
    - 11.1.1.1.4 US: North America Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.1.1.1.4.1 US: North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
    - 11.1.1.1.4.2 US: North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
    - 11.1.1.1.5 US: North America Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
    - 11.1.1.1.6 US: North America Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
    - 11.1.1.1.6.1 US: North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
    - 11.1.1.1.7 US: North America Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.1.1.2 Canada
    - 11.1.1.2.1 Overview
    - 11.1.1.2.2 Canada: North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.2.3 Canada: North America Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
    - 11.1.1.2.4 Canada: North America Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.1.1.2.4.1 Canada: North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
    - 11.1.1.2.4.2 Canada: North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
    - 11.1.1.2.5 Canada: North America Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
    - 11.1.1.2.6 Canada: North America Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
    - 11.1.1.2.6.1 Canada: North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
    - 11.1.1.2.7 Canada: North America Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)
  - 11.1.1.3 Mexico
    - 11.1.1.3.1 Overview
    - 11.1.1.3.2 Mexico: North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    - 11.1.1.3.3 Mexico: North America Infectious Disease Diagnostics Market, by Product, 2020-2030 (US$ Million)
    - 11.1.1.3.4 Mexico: North America Infectious Disease Diagnostics Market, by Technology, 2020-2030 (US$ Million)
    - 11.1.1.3.4.1 Mexico: North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology, 2020-2030 (US$ Million)
    - 11.1.1.3.4.2 Mexico: North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology, 2020-2030 (US$ Million)
    - 11.1.1.3.5 Mexico: North America Infectious Disease Diagnostics Market, by Application Type, 2020-2030 (US$ Million)
    - 11.1.1.3.6 Mexico: North America Infectious Disease Diagnostics Market, by Testing Type, 2020-2030 (US$ Million)
    - 11.1.1.3.6.1 Mexico: North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type, 2020-2030 (US$ Million)
    - 11.1.1.3.7 Mexico: North America Infectious Disease Diagnostics Market, by End User, 2020-2030 (US$ Million)

12. Industry Landscape

12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
- 12.3.1 Overview
12.4 Inorganic Developments
- 12.4.1 Overview

13. Company Profiles

13.1 Abbott Laboratories
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Bruker Corp
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Cardinal Health Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 F. Hoffmann-La Roche Ltd
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Trinity Biotech Plc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Danaher Corp
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Bio-Rad Laboratories Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 ACON Laboratories Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 DiaSorin SpA
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments

14. Appendix

14.1 About Us
14.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. North America Infectious Disease Diagnostics Market Segmentation
Table 2. Infectious Diseases and Fundings
Table 3. North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 4. North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 5. North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 6. US: North America Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 7. US: North America Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 8. US North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 9. US: North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 10. US: North America Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)
Table 11. US: North America Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 12. US: North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 13. US: North America Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 14. Canada: North America Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 15. Canada: North America Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 16. Canada: North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 17. Canada: North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 18. Canada: North America Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)
Table 19. Canada: North America Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 20. Canada: North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 21. Canada: North America Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 22. Mexico: North America Infectious Disease Diagnostics Market, by Product - Revenue and Forecast to 2030 (US$ Million)
Table 23. Mexico: North America Infectious Disease Diagnostics Market, by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 24. Mexico: North America Infectious Disease Diagnostics Market, for Immunodiagnostics by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 25. Mexico: North America Infectious Disease Diagnostics Market, for Molecular-Based Diagnostic Techniques by Technology - Revenue and Forecast to 2030 (US$ Million)
Table 26. Mexico: North America Infectious Disease Diagnostics Market, by Application Type - Revenue and Forecast to 2030 (US$ Million)
Table 27. Mexico: North America Infectious Disease Diagnostics Market, by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 28. Mexico: North America Infectious Disease Diagnostics Market, for Human Testing by Testing Type - Revenue and Forecast to 2030 (US$ Million)
Table 29. Mexico: North America Infectious Disease Diagnostics Market, by End User - Revenue and Forecast to 2030 (US$ Million)
Table 30. Organic Developments Done By Companies
Table 31. Inorganic Developments Done By Companies
Table 32. Glossary of Terms, North America Infectious Disease Diagnostics Market

List Of Figures

Figure 1. North America Infectious Disease Diagnostics Market Segmentation, By Country
Figure 2. North America Infectious Disease Diagnostics Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Infectious Disease Diagnostics Market Revenue (US$ Mn), 2022 - 2030
Figure 5. North America Infectious Disease Diagnostics Market Revenue Share, by Product, 2022 & 2030 (%)
Figure 6. Kits & Reagents: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Instruments: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Software & Services: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. North America Infectious Disease Diagnostics Market Revenue Share, by Technology, 2022 & 2030 (%)
Figure 10. Biosensor-based: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Immunodiagnostics: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Molecular-Based Diagnostic Techniques: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Clinical Biology: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. North America Infectious Disease Diagnostics Market Revenue Share, by Application Type, 2022 & 2030 (%)
Figure 16. Point-of-Care Testing: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Laboratory Testing: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. North America Infectious Disease Diagnostics Market Revenue Share, by Testing Type, 2022 & 2030 (%)
Figure 19. Human Testing: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Veterinary Testing: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. North America Infectious Disease Diagnostics Market Revenue Share, by End User, 2022 & 2030 (%)
Figure 22. Diagnostic Laboratories: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Hospitals and Clinics: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Research Institutes: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Homecare Settings: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: North America Infectious Disease Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. North America: Infectious Disease Diagnostics Market, by Key Country - Revenue (2022) (US$ Million)
Figure 28. North America Infectious Disease Diagnostics Market, By Key Countries, 2022 and 2030 (%)
Figure 29. US: North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 30. Canada: North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 31. Mexico: North America Infectious Disease Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
Figure 32. Growth Strategies Done by the Companies in the Market, (%)